ロード中...
Retinoic acid and 6-formylindolo(3,2–b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML
In non-APL AML, identification of a signaling signature would predict potentially actionable targets to enhance differentiation effects of all-trans-retinoic acid (RA) and make combination differentiation therapy realizable. Components of such a signaling machine/signalsome found to drive RA-induced...
保存先:
| 出版年: | Leuk Lymphoma |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586535/ https://ncbi.nlm.nih.gov/pubmed/30570341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1543880 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|